share_log

2 Fantastic Growth Stocks to Buy Right Now

2 Fantastic Growth Stocks to Buy Right Now

現在買入的2只非常適合創業板的成長股
The Motley Fool ·  07/23 15:45
big

When building a well-diversified portfolio of stocks to hold for the long term, stocks with significant growth potential are some of the most important you can buy. Luckily for investors, the TSX is filled with a tonne of fantastic growth stocks that you can buy cheaply right now and plan to hold in your portfolio for years.

當爲長揸的股票建立多元化的投資組合時,具有顯著增長潛力的股票是您可以購買的最重要的股票之一。幸運的是,TSX充滿了許多您可以便宜購買並計劃持有多年的夢幻增長股。

Finding growth stocks with years of potential is essential due to the incredible power of compound interest. However, when you can also buy these stocks while theyâre undervalued, their growth potential increases considerably.

由於複利的驚人威力,尋找具有多年潛力的成長型股票至關重要。然而,當您能夠在這些股票被低估時購買它們,它們的增長潛力就會大大增加。

So, with that in mind, if youâre looking for high-quality investments to buy right now and hold for years to come, here are two of the best growth stocks to consider today.

因此,如果您正在尋找高質量的投資,以便立即購買並持有數年,請考慮以下兩個今天值得考慮的最佳增長股票。

One of the best growth stocks on the TSX to buy right now

TSX上最好的增長股票之一

Ever since the pandemic ended, WELL Health Technologies (TSX:WELL), a diversified healthcare technology stock, has been trading ultra-cheap.

自從疫情結束,WELL Health Technologies (TSX:WELL)成爲了一隻價格超級便宜,多元化醫療科技公司的股票。

WELL saw a huge boost during the pandemic, and despite continuing to expand its operations rapidly and grow its revenue generation and earnings potential, the stock has consistently traded undervalued for years now.

WELL在疫情期間大幅增長,儘管不斷擴大業務並增加營業收入和盈利潛力,但該股票依然多年被低估。

However, after its recent investor day in June, WELL has now begun to see significant momentum, making it one of the best growth stocks to buy right now while itâs still cheap.

然而,在6月的最近一個投資者日之後,WELL現在已經開始看到顯着的動量,使其成爲一隻可以在低位買入的最好的增長股票之一。

Not only does it have the opportunity to sell off some of its rapidly growing healthcare technology businesses to recycle capital and generate value for shareholders, but it continues to acquire healthcare clinics across Canada and is now the largest owner/operator of outpatient medical clinics in the country.

它不僅有機會出售其快速增長的醫療科技業務來回收資本併爲股東創造價值,而且還在加拿大收購醫療診所,現在是該國最大的門診醫療診所所有者/運營商。

That is significant because for years WELL has demonstrated the value it can create by acquiring these clinics and improving their economics. Furthermore, its artificial intelligence-powered solutions have already begun to help improve the efficiency of the clinics and continue to create significant growth potential for the stock going forward.

這非常重要,因爲多年來WELL已經展示了通過收購這些診所並改善其經濟情況所創造的價值。此外,其人工智能驅動的解決方案已經開始幫助提高診所的效率,並繼續爲股票創造顯着增長潛力。

So, itâs no surprise that even after years of rapid growth, WELL is still expected to expand its business rapidly throughout 2024 and 2025.

因此,令人驚訝的是,即使經過多年的快速增長,WELL仍有望在2024年和2025年期間快速擴大業務。

In fact, analysts are forecasting that WELLâs revenue will grow by another 25% this year. More importantly, its profitability is expected to see a significant jump as well. Analysts expect a 31% increase in normalized earnings per share (EPS) this year and another 25.3% gain in normalized EPS next year.

事實上,分析師預測WELL的營業收入今年將增長25%。更重要的是,預計其盈利能力也將實現顯着增長。分析師預計今年歸一化每股收益(EPS)將增加31%,明年將再次增長25.3%。

Itâs also not surprising that given these estimates, analysts are highly bullish on the healthcare stock. Right now, of the seven analysts covering WELL, six have awarded it a buy rating, with the remaining analyst calling it a hold. In addition, its average analyst target price of $7.18 is a roughly 50% premium to where WELL trades today.

很明顯,鑑於這些預測,分析師對這種醫療保健股票持高度看好態度。現在,對於這七家覆蓋WELL的分析師中,有六家給予買入評級,其餘分析師給予持有評級。此外,它的平均分析師目標價爲7.18美元,大約是WELL今天的交易價格的50%左右的溢價。

So, if youâre looking for a fantastic growth stock to buy right now and hold for years, WELL is certainly a stock to add to your watchlist.

因此,如果您正在尋找一隻絕佳的增長股票,以便立即購買並持有多年,那麼WELL肯定是要添加到您的自選列表中的股票之一。

A top TSX stock in the midst of a recovery

正在復甦中的頂尖TSX股票

Another impressive growth stock to buy now before it fully recovers in price is Aritzia (TSX:ATZ), the rapidly growing consumer discretionary stock.

在其價格完全恢復之前,購買另一隻令人印象深刻的增長股票ATZ(TSX)是現在的好時機,這是一家快速擴張的消費者自主股票。

As a predominantly womenâs fashion retailer, Aritziaâs rapid expansion of its network of stores across North America has been incredible, and it continues to have significant growth potential going forward.

作爲一家主要面向女性的時裝零售商,Aritzia在北美不斷擴張其門店網絡是令人難以置信的,並且它在未來仍具有巨大的增長潛力。

The stock was slightly impacted in the last couple of years due to a slowdown in the economy and surging inflation. However, that already appears to be behind it.

由於經濟放緩和通貨膨脹飆升,該股票在過去幾年中有所影響。然而,這似乎已經過去了。

Itâs already reported stellar earnings to begin its fiscal 2025 year, and analysts are predicting a nearly 100% jump in normalized earnings per share for the full year, giving it a forward price-to-earnings ratio of 23.5 times today, well below its five-year average of 36.4 times.

它已經報告了出色的第一財季業績,分析師預計全年歸一化每股收益將猛增近100%,今天的前瞻性市盈率爲23.5倍,遠低於其五年平均水平36.4倍。

Furthermore, just like WELL, six analysts rate Aritzia a buy, with the remaining analysts calling it a hold.

此外,就像WELL一樣,有6位分析師給Aritzia買入評級,其餘分析師稱其爲持有級別。

So, while its average analyst target price is just $48.57, itâs already starting to see upgrades to those targets after reporting strong first-quarter earnings. It should continue to see increases to its target price if it can stay on track and continue rebounding throughout the rest of the year.

因此,在其平均分析師目標價僅爲48.57美元的同時,一旦報告強勁的第一季度業績,就已經開始看到目標的提升。如果它能夠保持在軌道上並在今年餘下的時間內繼續反彈,其目標價格應該會繼續增長。

Therefore, while Aritzia remains undervalued, itâs certainly one of the top growth stocks on the TSX to buy right now.

因此,雖然艾瑞澤亞的估值仍然偏低,但它絕對是目前在 TSX 上買入的頂級創業板股票之一。

The post 2 Fantastic Growth Stocks to Buy Right Now appeared first on The Motley Fool Canada.

發帖:現在買入的兩個非常棒的創業板股票

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論